Two Sigma Securities, LLC Insulet Corp Call Options Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$180.69 - $239.01 $271,035 - $358,515	1,500 Added 34.88%	5,800 $1.35 Million
Q2 2024 Aug 14, 2024	SELL	$161.02 - $206.98 $1.51 Million - $1.95 Million	-9,400 Reduced 68.61%	4,300 $867,000
Q1 2024 May 15, 2024	SELL	$163.6 - $209.11 $425,360 - $543,686	-2,600 Reduced 15.95%	13,700 $2.35 Million
Q4 2023 Feb 14, 2024	BUY	$127.77 - $221.42 $1.09 Million - $1.88 Million	8,500 Added 108.97%	16,300 $3.54 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $866,151 - $1.63 Million	5,600 Added 254.55%	7,800 $1.24 Million
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $599,456 - $726,506	2,200 New	2,200 $634,000
Q2 2022 Aug 15, 2022	SELL	$186.4 - $279.02 $149,120 - $223,216	-800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$194.8 - $275.7 $155,840 - $220,560	800 New	800 $213,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.